334 related articles for article (PubMed ID: 1245600)
1. Clinical significance of serum properdin levels and properdin deposition in the dermal-epidermal junction in systemic lupus erythematosus.
Schrager MA; Rothfield NF
J Clin Invest; 1976 Jan; 57(1):212-21. PubMed ID: 1245600
[TBL] [Abstract][Full Text] [Related]
2. Family study of systemic lupus erythematosus: analysis of the clinical history, skin immunofluorescence, and serologic parameters.
Lowenstein MB; Rothfield NF
Arthritis Rheum; 1977; 20(7):1293-1303. PubMed ID: 334183
[TBL] [Abstract][Full Text] [Related]
3. Immunopathology of the end-stage kidney. Immunoglobulin and complement component deposition in nonimmune disease.
Velosa J; Miller K; Michael AF
Am J Pathol; 1976 Jul; 84(1):149-62. PubMed ID: 779494
[TBL] [Abstract][Full Text] [Related]
4. Demonstration of beta 1H globulin together with C3 in the dermal-epidermal junction of patients with systemic lupus erythematosus.
Carlo JR; Rothfield NF; Ruddy S
Arthritis Rheum; 1979 Jan; 22(1):13-8. PubMed ID: 83148
[TBL] [Abstract][Full Text] [Related]
5. Dermal-epidermal deposition of complement components and properdin in systemic lupus erythematosus.
Jordon RE; Schroeter AL; Winkelmann RK
Br J Dermatol; 1975 Mar; 92(3):263-71. PubMed ID: 1096924
[TBL] [Abstract][Full Text] [Related]
6. The lupus band test as a measure of disease activity in systemic lupus erythematosus.
Halberg P; Ullman S; Jørgensen F
Arch Dermatol; 1982 Aug; 118(8):572-6. PubMed ID: 7103527
[TBL] [Abstract][Full Text] [Related]
7. Immunoglobulin and complement deposition in skin of rheumatoid arthritis and systemic lupus erythematosus patients.
Schroeter AL; Conn DL; Jordon RE
Ann Rheum Dis; 1976 Aug; 35(4):321-6. PubMed ID: 970989
[TBL] [Abstract][Full Text] [Related]
8. Pathways of complement activation in chronic discoid lupus: serologic and immunofluorescence studies.
Schrager MA; Rothfield NF
Arthritis Rheum; 1977 Mar; 20(2):637-45. PubMed ID: 322668
[TBL] [Abstract][Full Text] [Related]
9. Relative importance of C3b inactivator and beta 1H globulin in the modulation of the properdin amplification loop in systemic lupus erythematosus.
Whaley K; Schur PH; Ruddy S
Clin Exp Immunol; 1979 Jun; 36(3):408-14. PubMed ID: 114347
[TBL] [Abstract][Full Text] [Related]
10. Deposits of immunoglobulins and complement C3 in clinically normal skin of patients with lupus erythematosus.
Ullman S; Halberg P; Wolf-Jürgensen P
Acta Derm Venereol; 1975; 55(2):109-12. PubMed ID: 48312
[TBL] [Abstract][Full Text] [Related]
11. Immunoglobulin classes of DNA binding activity in serum and skin in systemic lupus erythematosus.
Pennebaker JB; Gilliam JN; Ziff M
J Clin Invest; 1977 Dec; 60(6):1331-8. PubMed ID: 334800
[TBL] [Abstract][Full Text] [Related]
12. The clinical utility of the lupus band test.
Smith CD; Marino C; Rothfield NF
Arthritis Rheum; 1984 Apr; 27(4):382-7. PubMed ID: 6608947
[TBL] [Abstract][Full Text] [Related]
13. Mannose binding lectin deposition in skin of lupus erythematosus patients: a case series.
Wallim LR; Nisihara R; Skare T; Mocelin V; Messias-Reason IJ
Hum Immunol; 2014 Jul; 75(7):629-32. PubMed ID: 24798938
[TBL] [Abstract][Full Text] [Related]
14. The significance of serial measurements of serum complement C3 and C4 components and DNA binding capacity in patients with lupus nephritis.
Garin EH; Donnelly WH; Shulman ST; Fernandez R; Finton C; Williams RL; Richard GA
Clin Nephrol; 1979 Oct; 12(4):148-55. PubMed ID: 315852
[TBL] [Abstract][Full Text] [Related]
15. Variability of the lupus band test. Results in 18 patients with systemic lupus erythematosus.
Jacobs MI; Schned ES; Bystryn JC
Arch Dermatol; 1983 Nov; 119(11):883-9. PubMed ID: 6357104
[TBL] [Abstract][Full Text] [Related]
16. Complement breakdown products in plasma from patients with systemic lupus erythematosus and patients with membranoproliferative or other glomerulonephritis.
Perrin LH; Lambert PH; Miescher PA
J Clin Invest; 1975 Jul; 56(1):165-76. PubMed ID: 1141431
[TBL] [Abstract][Full Text] [Related]
17. Skin immunoflorescence in patients with systemic lupus erythematosus, SLE. Relationship between the immunohistochemical pattern and systemic activity.
Ojeda-Durán S; Vargas-Rosendo R; Fernández-Diez J
Arch Invest Med (Mex); 1980; 11(2):215-26. PubMed ID: 7000021
[TBL] [Abstract][Full Text] [Related]
18. Anti-C1q antibodies and antiendothelial cell antibodies in systemic lupus erythematosus - relationship with disease activity and renal involvement.
Oelzner P; Deliyska B; Fünfstück R; Hein G; Herrmann D; Stein G
Clin Rheumatol; 2003 Oct; 22(4-5):271-8. PubMed ID: 14576989
[TBL] [Abstract][Full Text] [Related]
19. Chronic urticaria-like lesions in systemic lupus erythematosus. A review of 12 cases.
O'Loughlin S; Schroeter AL; Jordon RE
Arch Dermatol; 1978 Jun; 114(6):879-83. PubMed ID: 352270
[TBL] [Abstract][Full Text] [Related]
20. A controlled and blinded study of immunoreactant deposition at the dermal-epidermal junction of patients with primary fibrositis syndrome.
Caro XJ; Wolfe F; Johnston WH; Smith AL
J Rheumatol; 1986 Dec; 13(6):1086-92. PubMed ID: 3550073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
